Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Diego Diaz

Pediatric Gastroenterology Hollywood, FL Medical Doctor

NPI 1164419107 CMS profile 143836

1150 N 35Th Ave, Suite 545, Hollywood, FL 33021

Open in the dashboard

General payments

$7,452

287 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Diego Diaz of Hollywood, FL is reported in the CMS Open Payments database as having received $7,452 across 287 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,280 59
2024 General $1,240 46
2023 General $1,116 49
2022 General $1,001 34
2021 General $613 37
2020 General $1,655 34
2019 General $546 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Diego Diaz
  • Pediatric Gastroenterology median
  • Middle half of Pediatric Gastroenterology
  • National median

In program year 2025, general payments to Diego Diaz were reported at $1,280. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.

Show as a table
Year Diego Diaz Pediatric Gastroenterology median Middle half National median
2019 $546 $131 $41–$311 $163
2020 $1,655 $79 $23–$223 $114
2021 $613 $104 $32–$321 $132
2022 $1,001 $125 $37–$331 $149
2023 $1,116 $169 $55–$440 $160
2024 $1,240 $196 $73–$563 $164
2025 $1,280 $194 $81–$540 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. QOL Medical, LLC $2,090 73 payments
  2. Janssen Biotech, Inc. $1,174 50 payments
  3. AbbVie, Inc. $1,142 51 payments
  4. Genzyme Corporation $912 40 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $605 20 payments
  6. Regeneron Healthcare Solutions, Inc. $286 6 payments
  7. Ipsen Biopharmaceuticals, Inc $283 13 payments
  8. Janssen Scientific Affairs, LLC $227 2 payments
  9. Nestle HealthCare Nutrition Inc. $97 5 payments
  10. Alfasigma USA, Inc. $82 4 payments
  11. Other $554 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,194 283 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,150 2 payments
  3. Education $108 2 payments
Products named General payments · program years 2019–2025
  1. Sucraid Therapy For Csid $1,501 40 payments
  2. STELARA $1,301 47 payments
  3. DUPIXENT $912 40 payments
  4. HUMIRA $824 38 payments
  5. GATTEX $421 12 payments
  6. Sucraid Therapy For Csid $419 24 payments
  7. SIMPONI ARIA $388 19 payments
  8. SIMPONI $388 19 payments
  9. REMICADE $304 10 payments
  10. TREMFYA $294 15 payments
  11. Other $1,946 81 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

287 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Gastroenterology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record